162 related articles for article (PubMed ID: 35862569)
21. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
Bakr F; Wain EM; Barlow R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
[TBL] [Abstract][Full Text] [Related]
22. Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4.
Ardeleanu V; Moroianu LA; Sava A; Tebeica T; Jecan RC; Moroianu M; Tatu AL
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363575
[TBL] [Abstract][Full Text] [Related]
23. Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria.
Bakr F; Wain EM; Wong S; Palmer R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e190-e196. PubMed ID: 33989212
[TBL] [Abstract][Full Text] [Related]
24. Clonal B-cell proliferations developing in the background of primary cutaneous CD4
Ates Ozdemir D; Akdoğan N; Okay M; Uner A; Saglam A
J Cutan Pathol; 2022 Nov; 49(11):971-977. PubMed ID: 35871674
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological analysis of primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoproliferative disorder: a retrospective study of 22 patients.
Shi HZ; Zhang J; Xiong JS; Gan L; Jiang YQ; Xu XL; Zhang W; Zeng XS; Sun JF; Chen H
Int J Dermatol; 2021 Apr; 60(4):497-502. PubMed ID: 33369742
[TBL] [Abstract][Full Text] [Related]
26. Primary Cutaneous CD4 Small/Medium T-Cell Lymphoproliferative Disorder Following COVID-19 Vaccination-What Do We Know about Lymphoproliferative Disorders and Cutaneous Lymphomas after COVID-19 Vaccination? A Report of an Atypical Case and a Review of the Literature.
De la Torre-Gomar FJ; Llamas-Molina JM; Pegalajar-García MD; Pérez-Valencia C; Carrero-Castaño A; Ruiz-Villaverde R
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541710
[TBL] [Abstract][Full Text] [Related]
27. Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature.
Baum CL; Link BK; Neppalli VT; Swick BL; Liu V
J Am Acad Dermatol; 2011 Oct; 65(4):739-748. PubMed ID: 21641676
[TBL] [Abstract][Full Text] [Related]
28. Dermoscopy of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Rodríguez-Lomba E; Lobato-Berezo A; Pulido-Pérez A; Parra-Blanco V; Avilés-Izquierdo JA
Int J Dermatol; 2020 Jun; 59(6):755-757. PubMed ID: 32010958
[No Abstract] [Full Text] [Related]
29. Primary cutaneous CD4
Besch-Stokes JG; Costello CM; Severson KJ; Bhullar P; Montoya J; Butterfield RJ; DiCaudo DJ; Comfere N; Sluzevich J; Rule W; Craig FE; Rosenthal A; Pittelkow MR; Mangold AR
J Am Acad Dermatol; 2022 May; 86(5):1167-1169. PubMed ID: 33915243
[No Abstract] [Full Text] [Related]
30. Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder Mimicking Jessner Lymphocytic Infiltrate and Tumid Lupus-A Report of Two Cases.
Yi LG; Gru AA
Am J Dermatopathol; 2021 Dec; 43(12):e293-e297. PubMed ID: 34001748
[TBL] [Abstract][Full Text] [Related]
31. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group.
Beltzung F; Ortonne N; Pelletier L; Beylot-Barry M; Ingen-Housz-Oro S; Franck F; Pereira B; Godfraind C; Delfau MH; D'Incan M; Vergier B
Am J Surg Pathol; 2020 Jul; 44(7):862-872. PubMed ID: 32271188
[TBL] [Abstract][Full Text] [Related]
32. Decrease of 5-hydroxymethylcytosine in primary cutaneous CD4
Hu J; Zhang X; Zhao L; Zhao Q; Geng S
An Bras Dermatol; 2024; 99(1):27-33. PubMed ID: 37657958
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous CD4+ small to medium-size pleomorphic T-cell lymphoma in a 12-year-old girl.
Volks N; Oschlies I; Cario G; Weichenthal M; Fölster-Holst R
Pediatr Dermatol; 2013; 30(5):595-9. PubMed ID: 23756295
[TBL] [Abstract][Full Text] [Related]
34. Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.
Obiorah IE; Karrs J; Brown L; Wang HW; Karai LJ; Pham TH; Pham TA; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):344-353. PubMed ID: 36598455
[TBL] [Abstract][Full Text] [Related]
35. Two women with primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder during pregnancy.
Gambichler T; Scheel CH; Kock K; Klapper W; Doerler M; Boms S
Clin Exp Dermatol; 2023 Apr; 48(5):533-535. PubMed ID: 36763762
[No Abstract] [Full Text] [Related]
36. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous small/medium CD4
Xu J; Huang Q
Blood; 2018 Aug; 132(7):765. PubMed ID: 30115635
[No Abstract] [Full Text] [Related]
38. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
Lan TT; Brown NA; Hristov AC
Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound findings in case series of patients with primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Recio-Monescillo M; Mendoza-Cembranos MD; Torre-Castro J; Moya-Martínez C; Ruffin-Vicente B; Díaz-Recuero JL; Córdoba R; López-Robles J; Pelayo I; Rodríguez-Pinilla M; Requena L
J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):e320-e322. PubMed ID: 37907275
[No Abstract] [Full Text] [Related]
40. Multifocal CD4+ Primary Cutaneous Small/Medium Lymphoproliferative Disorder Successfully Treated With Low-Dose Oral Methotrexate: A Case Report.
Dimassi AB; Howlett C; Phua CW
Cureus; 2020 Jun; 12(6):e8534. PubMed ID: 32665881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
